We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$18.4B
AUM Growth
+$991M
Cap. Flow
+$652M
Cap. Flow %
3.54%
Top 10 Hldgs %
30.84%
Holding
2,900
New
51
Increased
2,117
Reduced
295
Closed
90

Sector Composition

Rank Sector Weight
1 Technology 30.12%
2 Financials 12.96%
3 Consumer Discretionary 11.52%
4 Healthcare 10.04%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENTA icon
2826
Enanta Pharmaceuticals
ENTA
$393M
-11,454
Closed -$119K
FHTX icon
2827
Foghorn Therapeutics
FHTX
$394M
-15,898
Closed -$148K
FLL icon
2828
Full House Resorts
FLL
$83.5M
-5,376
Closed -$27K
FRGE
2829
DELISTED
Forge Global Holdings
FRGE
-885
Closed -$17.4K
GBIO
2830
DELISTED
Generation Bio
GBIO
-430
Closed -$10.6K
HLLY icon
2831
Holley
HLLY
$384M
-9,810
Closed -$28.9K
IGMS
2832
DELISTED
IGM Biosciences
IGMS
-8,997
Closed -$149K
INO icon
2833
Inovio Pharmaceuticals
INO
$79.6M
-15,167
Closed -$87.7K
ISPR icon
2834
Ispire Technology
ISPR
$99.3M
-11,764
Closed -$73K
LAZR
2835
DELISTED
Luminar Technologies
LAZR
-13,196
Closed -$178K
LNZA icon
2836
LanzaTech
LNZA
$67.1M
-179
Closed -$34.2K
LXRX icon
2837
Lexicon Pharmaceuticals
LXRX
$1.05B
-55,182
Closed -$86.6K
LYEL icon
2838
Lyell Immunopharma
LYEL
$347M
-1,814
Closed -$50.1K
MODV
2839
DELISTED
ModivCare
MODV
-7,240
Closed -$103K
NAUT icon
2840
Nautilus Biotechnolgy
NAUT
$114M
-30,613
Closed -$87.2K
NKTX icon
2841
Nkarta
NKTX
$171M
-31,197
Closed -$141K
OPRX icon
2842
OptimizeRx
OPRX
$132M
-10,083
Closed -$77.8K
PAYS icon
2843
Paysign
PAYS
$723M
-3,515
Closed -$12.9K
PEPG icon
2844
PepGen
PEPG
$201M
-9,420
Closed -$80.5K
PGEN icon
2845
Precigen
PGEN
$2.45B
-2,631
Closed -$2.49K
POWW icon
2846
Outdoor Holding Co
POWW
$267M
-59,084
Closed -$84.5K
PSNY icon
2847
Polestar Automotive Holding UK
PSNY
$1.99B
-513
Closed -$26.5K
PYXS icon
2848
Pyxis Oncology
PYXS
$201M
-18,818
Closed -$69.1K
QRHC icon
2849
Quest Resource Holding
QRHC
$30M
-10,285
Closed -$82.1K
FLNA
2850
Filana Therapeutics
FLNA
$45.1M
-22,699
Closed -$668K

Similar funds

MetLife Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, MetLife Investment Management held 2,900 positions worth $18.4B, up 5.7% from $17.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

MetLife Investment Management deployed $652M of net new capital in Q4 2024, opening 51 new positions and adding to 2,117 existing holdings. Its largest new stake was Flex: 211,786 shares worth $8.13M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Arista Networks, an estimated $13.8M trimmed.

  • MetLife Investment Management's largest Q4 2024 buy was Flex: 211,786 shares worth $8.13M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $117M increase.
  • MetLife Investment Management's biggest Q4 2024 reduction was Arista Networks, cutting an estimated $13.8M.
  • MetLife Investment Management fully exited Southwestern Energy Company in Q4 2024, selling an estimated $4.05M.
  • MetLife Investment Management's ten largest holdings make up 31% of its $18.4B portfolio in Q4 2024.
  • MetLife Investment Management opened 51 new positions and closed 90 in Q4 2024.
  • MetLife Investment Management's portfolio value rose 5.7% quarter-over-quarter to $18.4B.

Based on MetLife Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.